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Abstract
Purpose-This study sought to explore, for the first time, the effects of repeated maximal static and dynamic apnoeic 
attempts on the physiological milieu by assessing cerebral, cardiac and striatal muscle stress-related biomarkers in a 
group of elite breath-hold divers (EBHD). 
Methods-Sixteen healthy males were recruited (EBHD=8; controls=8). On two separate occasions EBHD performed 
two sets of five repeated maximal static apnoeas (STA) or five repeated maximal dynamic apnoeas (DYN). Controls 
performed a static eupnoeic protocol to negate any effects of water immersion and diurnal variation on haematology 
(CTL). Venous blood samples were drawn at 30, 90, and 180-mins after each protocol to determine S100β, neuron-
specific enolase (NSE), myoglobin and high sensitivity cardiac troponin T (hscTNT) concentrations.
Results-S100β and myoglobin concentrations were elevated following both apnoeic interventions (p<0.001; p≤0.028, 
respectively) but not after CTL (p≥0.348). S100β increased from baseline (0.024±0.005µg/L) at 30 (STA, +149%, 
p<0.001; DYN, +166%, p<0.001) and 90 mins (STA, +129%, p<0.001; DYN, +132%, p=0.008) following the last 
apnoeic repetition. Myoglobin was higher than baseline (22.3±2.7ng/mL) at 30 (+42%, p=0.04), 90 (+64%, p<0.001) 
and 180 mins (+49%, p=0.013) post-STA and at 90 mins (+63%, p=0.016) post-DYN. Post-apnoeic S100β and 
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from basal concentrations after the apnoeic (p≥0.146) nor following the eupnoeic (p≥0.553) intervention.  
Conclusions-This study suggests that a series of repeated maximal static and dynamic apnoeas transiently disrupt the 
blood-brain barrier and instigate muscle injury but do not induce neuronal-parenchymal damage or myocardial 
damage.  
Keywords: Hypoxaemia, Breath-hold, Diving, Myoglobin, Neuron-specific Enolase, S100β, Cardiac troponin, 
Apnoea
Introduction
Breath-hold diving continues to gain popularity and recognition as both a competitive and recreational sport. The 
continued progression of world records is astonishing, particularly given the extreme hypoxaemic hypercapnia and 
hydrostatic pressures these athletes endure; yet the continued pursuit of performance raises safety concerns 1. To date, 
a breadth of research exists that has delineated the physiological characteristics of breath-hold divers, as well as the 
responses that occur during and/or following prolonged apnoeic bouts (e.g., the diving response, trigeminocardiac 
reflex, splenic contractions, erythropoietic responses, etc.) 1-8. In contrast, there is a paucity of literature concerning 
the possible health implications associated with exposure to such activities 9-14.  
Emerging evidence indicates that a single, maximal static apnoeic attempt is capable of transiently disrupting the 
blood-brain barrier 9, 13 and instigates neuronal-parenchymal damage 11 but is not associated with cardiac injury 10, 15. 
Specifically, both Andersson et al. 9 and Bain et al. 13 reported significant increases in serum S100 calcium-binding 
protein β (S100β) at the end of a maximal static apnoea (~26%, 335 ± 38 s; ~40%, 307 ± 64 s, respectively), which is 
indicative of a potential perturbation of the blood-brain barrier. Similarly, in competitive breath-hold divers ~1 h 
following a single maximal static apnoeic attempt (mean ~5 min [range: 2.3–7.6 min]), total tau and amyloid β42 
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a prognostic indicator of traumatic brain injury 16, was shown to be significantly elevated (~70%) ~3 h following a 
combined bout of static and dynamic apnoeas 12. Taken together, these findings highlight the severity of physiological 
stress encountered by breath-hold divers during maximal apnoeic activity.  
To date, only one study has examined the physiological stress imposed by repeated apnoeic exposures on bodily 
organs (e.g., the heart) 15. Specifically, following repeated apnoeic dives (i.e., performed over a 5 h spearfishing 
competition) cardiac troponin I increased (+275%) as did brain natriuretic peptide (+229%), which is notable as both 
are markers of cardiac stress 15, 17. These increases were not evident following a single maximal static apnoeic attempt 
15, nor after a combined bout of static and dynamic apnoeas 12. However, to the best of our knowledge, no study has 
investigated the magnitude of physiological stress instigated by a series of repeated maximal static and/or dynamic 
apnoeic bouts on cerebral, cardiac, and striatal muscle markers. Contrary to apnoeic competitions (i.e., with the 
exception of spearfishing competitions), whereby athletes perform one maximal attempt per discipline; during training 
and spearfishing, breath-hold divers commonly perform a series of repeated sub-maximal and/or maximal attempts. 
Intermittent hypoxaemia of this nature is capable of upregulating the production of reactive oxygen species 18, 19, 
exacerbating oxidative stress levels 20, 21 as well as inflicting oxidative damage on cells, tissues and organs. 
Collectively, these observations reinforce the necessity for further studies to be undertaken to assess the possible 
health consequences associated with repeated apnoeic exposures.   
Duly, this study sought to explore the effects of repeated maximal static and dynamic apnoeic attempts on the 
physiological milieu by assessing cerebral (NSE and S100β), cardiac (cardiac troponin T) and striatal muscle 
(myoglobin) stress-related biomarkers in a group of elite breath-hold divers (EBHD). We hypothesised that both 
repeated maximal apnoeic modalities would be associated with significant physiological stress. 
Materials and Methods
Participants
Sixteen healthy males volunteered for this study and were differentiated into two groups: EBHD (n = 8) and controls 
(n = 8). All breath-hold divers actively participated in national and/or international competitions (Table 1) and the 
control group comprised of physically active individuals. Participants were non-smoking, habitual sea-level residents 
and provided written informed consent before the study. The study received institutional ethical approval and all 
experimental procedures were completed in accordance with the Declaration of Helsinki. The study was part of a 
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During each testing session participants reported to the laboratory at Leeds Beckett University (Leeds, England) after 
a 12 h fast and refrained from consuming caffeine- and alcohol-containing beverages. Additionally, participants were 
instructed to avoid physical activity and apnoea-related activities for 24 h prior to and during each testing day.  
**Table 1 about here**
Preliminary Resting Measurements  
Following arrival at the laboratory the participants’ height and body mass were assessed (Seca, Vogel & Halke, 
Germany) (Table 1). Thereafter, the participants underwent a 20-mins supine resting period and subsequently, two 
venous blood samples (5 mL) were drawn from a median cubital or basilic vein to assess for resting serum NSE, 
S100β, myoglobin and high sensitivity cardiac troponin T (hscTNT) concentrations (BD Vacutainer, 367954, UK).  
Familiarisation Session
Participants underwent a familiarisation session within 24 h of completing the baseline measurements to introduce 
them to the testing environment, trial conditions and requirements.  
**Figure 1 about here**
Apnoeic Protocols 
Within a week from completing the familiarisation session, participants reported to the swimming pool (~28 C) 
facilities and, under the supervision of a qualified safety diver(s) performed, on separate days (i.e., separated by ≥96 
h), in a Latin-Square fashion and randomised order (achieved using a computer-generated list of random numbers 
[https://www.randomizer.org/]) one of the following protocols: five repeated maximal dynamic apnoeas without fins 
(horizontal underwater swimming), or two sets of five maximal static apnoeic attempts (i.e., two sets separated by a 
10-mins seated rest; breath-holding performed in a prone/semi-seated position on the water surface) (Figure 1). To 
control for diurnal oscillations of the measured variables both apnoeic protocols were performed at the same time of 
the day.
Participants were instructed to hold their breath after a deep but not maximal inspiration, without prior 
hyperventilation or glossopharyngeal insufflation. After each maximal attempt, participants underwent a two-minute 
resting period whereby they were allowed to relax and breathe normally in a seated position, whilst remaining 
immersed in water up to waist height (Figure 1). This procedure was repeated five times per set and performance data 
(i.e., apnoeic duration and/or distance covered) were recorded during each maximal attempt (Figure 1). 
Control Protocol
To control any possible effects of whole-body immersion in water, a control group performed a static eupnoeic 
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collection timepoints of the static apnoea protocol (since the water exposures were longer in the static versus the 
dynamic apnoea protocol) and replaced apnoeas with normal breathing periods.  
Participants reported to the swimming pool facilities at the same time of day as during the apnoeic protocols and were 
immersed in water up to the neck.
Post-Apnoea Blood Sample
At completion of the apnoeic and control protocols, a cannula was inserted into a suitable median cubital or basilic 
vein of the participant’s arm and two venous blood samples were drawn at 30, 90 and 180 mins after the last 
apnoeic/eupnoeic repetition to determine the serum concentrations of circulating NSE, S100β, myoglobin and 
hscTNT.  
Blood Sample Treatment
Samples were gently inverted, allowed to coagulate at room temperature for 20 mins then centrifuged (4000 rpm for 
10 mins at 4C; ALC Multispeed Refrigerated Centrifuge, PK131R, UK) and the serum supernatants were frozen at - 
80C for subsequent analyses. 
Blood Analyses
Enzyme-linked immunosorbent assay (ELISA) was performed to assess serum concentrations of NSE (R&D Systems, 
Quantikine IVD ELISA, Human Enolase 2/Neuron-specific Enolase Immunoassay, DENL20, sensitivity 0.038 
ng/mL; intra-assay variability ~2.2%), S100β (R&D Systems, Human S100β Duo Set ELISA, DY1820; intra-assay 
variability ~4.5%) and myoglobin (Abcam, Human Myoglobin ELISA, ab108652, sensitivity 5 ng/mL; intra-assay 
variability ~5.4%). hscTNT was quantified by electro-chemiluminescence immunoassay (Cobas Analyser, Roche 
Diagnostics) (intra-assay variability ~6%). 
Statistical Analysis
All participants completed the protocols successfully and all data were statistically analysed using the IBM SPSS 
statistics software (Version 21, Armonk, NY). The Shapiro-Wilk test was used to assess normality, whereas 
homogeneity was assessed using Levene’s test. Sphericity was evaluated using Mauchly’s test of sphericity; for 
instances where the assumption of sphericity was violated, the Greenhouse-Geisser correction was applied. Repeated 
measures ANOVAs with Tukey’s post-hoc tests were used to assess within-group differences for baseline 
measurements and other timepoints for serum S100β, NSE, myoglobin, and hscTNT concentrations. Two-way 
ANOVAs were used to assess temporal differences between conditions. Data are reported as mean ± SD, with 
significance accepted at p < 0.05. Figures were constructed using GraphPad Prism (GraphPad Software, Version 7.0c, 
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Apnoeic Performances 
Mean static apnoea duration was 218 s (range 130-350 s) and mean dynamic apnoea distance covered without fins 
was 71 m (range 46-126 m).
S100β
Mean post-apnoeic S100β concentrations were significantly higher than baseline (0.024 ± 0.005 µg/L) following the 
static (p < 0.001) and dynamic (p < 0.001) apnoea protocols, while no differences were observed during the control 
protocol (p = 0.348) (Figure 2a). Notably, S100β concentrations were greater than baseline at 30 (static, +149%, 0.059 
± 0.019 µg/L, p < 0.001; dynamic, +166%, 0.061 ± 0.019 µg/L, p < 0.001) and 90 mins (static, +129%, 0.055 ± 0.019 
µg/L, p < 0.001; dynamic, +132%, 0.054 ± 0.018 µg/L, p = 0.008) after the last apnoeic repetition but not at 180 mins 
(static, +32%, 0.031 ± 0.008 µg/L, p = 0.676; dynamic, +46%, 0.035 ± 0.011 µg/L, p = 0.432). In addition, mean post-
apnoeic S100β concentrations were significantly higher than control (static, p < 0.001; dynamic, p = 0.002) at 30 (p < 
0.001), 90 (p < 0.001) and 180 mins (p ≤ 0.006), whereas no differences were documented between the apnoeic 
protocols (p = 0.622) (Figure 2a).
Neuron-Specific Enolase 
There was no effect of the apnoeic (static, p = 0.146; dynamic, p = 0.836) nor eupnoeic (p = 0.988) interventions on 
serum NSE concentrations compared with baseline (EBHD, 2.91 ± 0.55 pg/mL; control, 3.32 ± 0.63 pg/mL). 
Moreover, there were no between-protocol differences (static vs. dynamic, p = 0.682; apnoeic vs. control, p ≥ 0.127) 
(Figure 2b).
High Sensitivity Cardiac Troponin T
hscTNT concentrations were not significantly different from baseline (EBHD, 5 ± 1 ng/L; control, 6 ± 1 ng/L) neither 
after the apnoeic interventions (p ≥ 0.224) nor following the control protocol (6 ± 1 ng/L, p = 0.553) (Figure 2c). In 
addition, there were no between-protocol differences (static vs. dynamic, p = 0.384; apnoeic vs. control, p ≥ 0.163) 
(Figure 2c). 
**Figure 2 about here**
Myoglobin
There was a significant increase in myoglobin concentrations after both the static (p < 0.001) and dynamic (p = 0.028) 
apnoea protocols, whereas no significant differences were denoted during control (p = 0.493) (Figure 3a).  
Specifically, myoglobin was significantly higher than baseline (22.3 ± 2.7 ng/mL) at 30 (+42%, 31.2 ± 3.3 ng/mL, p = 
0.040), 90 (+64%, 36.5 ± 11.5 ng/mL, p < 0.001) and 180 mins (+49%, 32.7 ± 7.3 ng/mL, p = 0.013) following the 
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only elevated at 90 mins (+63%, 35.5 ± 16.7 ng/mL, p = 0.016) after the last apnoeic repetition.  
**Figure 3 about here**
Resting baseline concentrations were significantly higher in the control group (EBHD, 22.3 ± 2.7 ng/mL; control, 27.5 
± 7.2 ng/mL, p = 0.047) (Figure 3a), as such, between-group differences (EBHD vs. control) were compared using 
delta percentage change (Figure 3b).  Myoglobin concentrations were significantly higher in response to the static (p < 
0.001) and dynamic apnoea (p = 0.004) protocols versus control, with no differences observed between the apnoeic 
protocols (p = 0.587) (Figure 3b).  
Discussion
This study examined the effects of repeated maximal apnoeic bouts on the physiological milieu by assessing cerebral, 
cardiac and skeletal muscle stress-related biomarkers. The primary findings demonstrate that a series of repeated 
maximal static and dynamic apnoeas incite a significant rise in S100β and myoglobin concentrations without any 
detectable changes in NSE nor hscTNT.  Taken together, our study suggests that a series of repeated maximal apnoeic 
attempts induce muscle injury and signify a potential, albeit minor blood-brain barrier disruption that appears to occur 
in the absence of neuronal-parenchymal damage.
S100β was significantly elevated from baseline only following the apnoeic interventions (Figure 2a).  S100β is a 
dimeric calcium-binding protein and is predominantly found in brain astrocytes 22.  Molecular communication 
between blood and the brain is largely prevented by the blood-brain barrier, a highly selective semipermeable border 
that is primarily composed of microvascular endothelial cells linked by tight and adherent junctions 22, 23.  Evidence 
suggests that astrocytic proteins extravasate into the serum only when the blood-brain barrier is breached 24, with a 
direct correlation reported between the venous concentration of S100β and the magnitude of the blood-brain barrier 
opening 25.  As such, our study suggests that a series of repeated maximal apnoeas is capable of transiently disrupting 
the blood-brain barrier. Considering that S100β exerts both neurotrophic and gliotrophic roles, it is presently unclear 
whether these increases serve a neuroprotective purpose (reactive astrogliosis) or rather represent a more menacing 
phenomenon (e.g., glial damage) 26.
In spite of never reaching pathological limits (> 0.10 µg/L) 27, the transient S100β increases documented in the present 
study are higher than those previously reported in competitive breath-hold divers following a single, dry maximal 
static apnoeic attempt 9, 13 and after a combined bout of static and dynamic apnoeas 12.  It is currently well accepted 
that intermittent hypoxaemia has a dose-dependent association (i.e., severity of hypoxaemia, duration of exposure) 
with an increase in the permeability of the blood-brain barrier 23. This response is believed to be orchestrated, at least 
in part, by reactive oxygen species 28, 29.  Interestingly, using a contrast-enhanced magnetic resonance imaging 
technique, Kanner et al. 25 observed a direct correlation between S100β concentrations and the magnitude of the 
opening of the blood-brain barrier. It is, therefore, tempting to speculate that the higher post-apnoeic S100β 
concentrations recorded in the present study may relate to the nature of our experimental design which comprised of a 
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It is generally accepted in the existing literature that S100β is a peripheral biochemical marker that is implicated in 
brain damage and neurodegenerative processes 22. It is also noteworthy that, in contrast to NSE, S100β is expressed in 
skeletal muscle myofibers and is locally released in response to myofiber damage and degeneration 30, 31. Moreover, 
S100β appears to be acutely important for skeletal muscle regeneration, due to its effects on myoblast proliferation 
through stimulation of extracellular signal-regulated kinase 1/2 32.  Indeed, neutralization of S100β release from 
acutely injured wild-type skeletal muscles reduced the population expansion of activated satellite cells, lowered the 
infiltration of injured tissues with macrophages as well as delayed the transition of macrophages from the M1 
(proinflammatory) to the M2 (anti-inflammatory and pro-regenerative) phase 31, 32; conjointly impairing the 
regenerative process. However, persistently high S100β levels may compromise the regenerative process by blocking 
myogenic differentiation 31 through inhibition of p38 mitogen-activated protein kinase 31, 32. Therefore, considering 
also the lack of changes in serum NSE, an alternative explanation for our findings might be that the elevated serum 
S100β levels may also stem from injured myofibers and represent a transient response to support the regeneration of 
injured skeletal muscle, by increasing the myoblast population in the local tissue area and preventing precocious 
myoblast differentiation. 
A series of repeated maximal apnoeas did not elicit any changes in circulating NSE concentrations (Figure 2b), 
attesting against any form of neuronal-parenchymal damage 16, 22.  Our findings are in contrast to those of Kjeld et 
al.12, whereby a significant rise in plasma NSE (from 14.5 ± 5.3 ng/mL to 24.6 ± 6.4 ng/mL) was documented ~3 h 
post (i.e., a range of post-apnoea timepoints 94-257 mins) a combined maximal bout of static and dynamic apnoeas.  It 
is noteworthy, however, that in the Kjeld et al.12 study, nine out of 17 breath-hold divers suffered a blackout episode 
(loss of consciousness) during their maximal attempts. Liner and Andersson 33 demonstrated that a blackout episode is 
associated with disruption of the blood-brain barrier as evidenced by a significant rise in serum S100β; increases that 
persisted for more than a day following the blackout incident.  Hence, it is perhaps unsurprising that increases in NSE 
have been reported by Kjeld et al. 12.  Contrastingly, in our study, none of our participants suffered a blackout nor 
exhibited any signs associated with loss of motor control (e.g., confusion, postural disturbance, spasms, speech 
problems, unresponsiveness, etc.). Taken together, our findings suggest that in the absence of a hypoxaemic syncope, 
a series of repeated maximal apnoeas does not incite neuronal-parenchymal damage. 
Myoglobin, a marker of muscle injury, was markedly elevated following both apnoeic interventions, while no changes 
were detected in the control group (Figure 3).  Our findings align with those of Marlinge et al. 15 who documented a 
similar rise in myoglobin following a 5 h spearfishing competition. These increases were not evident following a 
single maximal static apnoeic bout either with 10, or without glossopharyngeal insufflation 15.  Repeated maximal 
apnoeas have been linked with the upregulation of reactive oxygen species production 18 and aggravation of oxidative 
stress levels 20; undulations that, in the absence of sufficient antioxidant enzyme defences, are associated with 
oxidative damage19. Specifically, excessive free radical accumulation instigates muscle cell damage, resulting in 
dysregulation of sodium-calcium channel functioning, ultimately elevating intracellular free ionized calcium 34. This 
causes a resultant activation of calcium-dependent enzymes, which go on to further metabolise and rupture the 
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circulation 34. Therefore, our study demonstrates that, in a similar manner to repeated apnoeic dives, a series of 
repeated maximal static and dynamic apnoeas are associated with striatal muscle injury. 
The presently recorded myoglobin increases are comparable to those reported following a 90-min cycling exercise 
bout (power output held at 90W) 35 and those after eccentric-concentric exercise 36, but are substantially lower than 
those documented following a maximal endurance exercise bout performed under normoxic and hypoxic conditions 37.  
Collectively, the magnitude of myoglobin release denoted following a series of repeated maximal apnoeic epochs is 
well within the physiological limits (> 85 ng/ml), hence, our findings suggest that, at least in EBHD, the risk of 
sustaining rhabdomyolysis is very low 38.  However, what might seem surprising is that the post-apnoeic myoglobin 
concentrations did not differ across our apnoeic interventions (Figure 3), despite significantly lower end-apnoeic SpO2 
levels attained during the dynamic protocol (62 ± 10 % vs. 76 ± 5 %) 5. It is possible that the greater number of 
apnoeic repetitions incorporated in our static apnoea protocol (i.e., 10 vs. 5 repetitions) may have exacerbated the 
production of reactive oxygen species, consequently aggravating oxidative damage and promoting a similar release of 
myoglobin.  A measure of oxidative stress would have certainly provided additional insights to the mechanistic basis 
of this effect.    
To evaluate the magnitude of the cardiovascular burden imposed by repeated maximal apnoeic bouts we assessed 
hscTNT (Figure 2c), a regulatory protein that is expressed in cardiac myocytes and serves as a specific biomarker of 
myocardial injury 17.  Interestingly, post-apnoeic cardiac troponin T concentrations did not differ from baseline, 
suggesting that a series of repeated maximal apnoeic bouts does not incite myocardial injury.  Our data align well with 
earlier studies that showed no changes in cardiac troponin following a static apnoea packing-blackout that included 
episodes of asystole (cardiac troponin T 10), a single dry maximal static apnoeic attempt (cardiac troponin I 15), or a 
combined bout of static and dynamic apnoeas (hscTNT 12).  They also concur with longitudinal studies that did not 
unveil any cardiac abnormalities nor morphological alternations in EBHD 1, 39. Our findings do, however, contrast 
with those of Eichhorn et al. 14 who documented a significant rise in hscTNT 4 h following a single, maximal, dry 
static apnoeic attempt in a group of EBHD. It is noteworthy that this increase was lower [(pre) 2.2 ± 1.1 pg/ml vs. 
(post) 3.1 ± 1.7 pg/ml] than that recorded in the present study [(pre) 5.3 ± 0.5 ng/L vs. (3 h post) static 7 ± 1.6 ng/L 
and dynamic 6.9 ± 2.2 ng/L].  Thus, the current study signifies that a series of repeated maximal apnoeic attempts 
does not evoke myocardial damage.
To conclude, this study suggests that a series of repeated maximal static and dynamic apnoeas are associated with a 
potential, albeit minor, transient disruption of the blood-brain barrier as evidenced by a rise in S100β and instigate 
muscle injury as evinced by a rise in myoglobin but do not cause any detectable neuronal-parenchymal damage nor 
myocardial damage.
Perspective
Considering the growing popularity of breath-hold diving as a competitive and recreational sport, enhancing our 
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safety and medical standpoint1, 40.  In this context, the present study demonstrates that, in EBHD, a series of repeated 
maximal apnoeic bouts do not incite any detectable neuronal-parenchymal damage nor myocardial damage but are 
associated with a potential transient, albeit minor, disruption of the blood-brain barrier and muscle injury.  It is 
presently unclear whether these physiological responses are coherently expressed in non-divers.  As such, it is 
imperative that further research is conducted to evaluate the possible health risks associated with apnoeic training.  
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Table Legends
Table 1. Mean (± standard deviation [SD]) participant characteristics.
Figure Legends
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Figure 2.  Mean S100β (a), NSE (b) and hscTNT (c) concentrations from baseline to 180 mins after the apnoeic and 
eupnoeic protocols. Data are presented as mean ± SD. * denotes significant difference (p < 0.05) compared to 
baseline; † represents significant difference between apnoeic and eupnoeic protocols. S100β, S100 calcium-binding 
protein β; NSE, neuron-specific enolase; hscTNT, high sensitivity cardiac troponin T; µg/L, microgram per litre; 
pg/mL, picograms per millilitre; ng/L, nanograms per litre.
Figure 3.  Absolute (a) and delta percentage change (b) in mean myoglobin from baseline to 180 mins after the 
apnoeic and eupnoeic protocols. Data are presented as mean ± SD.  * denotes significant difference (p < 0.05) 
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Variables EBHD 
(n = 8) 
Control 
(n = 8) 
Age (yrs) 39 ± 7 28 ± 5 
Height (m) 1.8 ± 0.1 1.8 ± 0.1 
Body mass (kg) 84 ± 12 82 ± 11 
Body mass index (kg/m
2
) 26 ± 1.3 25 ± 2.2 
Years practicing apnoea (yrs) 7 ± 2 - 
Personal best static apnoea (s) 376 ± 39 - 
Personal best dynamic apnoea with fins (m) 193 ± 42 - 
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